Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs Royal Medical Center

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Royal Medical Center a 45. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

Royal Medical Center

#389 · Grade C · Watch List

Est. first month

From $450/mo (2.5 mg dose, compounded)

Save ~67% vs brand-name
Get this deal Full Royal Medical Center review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 45 an est. $99/mo first month, with no teaser step-up baked in. Royal Medical Center isn't out of it: Shoppers who want credentialed MD founder with itemized dose-strength pricing.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDRoyal Medical Center
Value Score89 (A)45 (C)
Est. first month$99/moFrom $450/mo (2.5 mg dose, compounded)
Save vs brand-name~93%~67%
Semaglutide$99/moNot disclosed
Tirzepatide$139/moFrom $450/mo (2.5 mg dose, compounded)
Both moleculesYesNo
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
22
bmiMD: 95. Royal Medical Center: 22.
84
No Teaser-Rate Bait
64
bmiMD: 84. Royal Medical Center: 64.
98
Nationwide Availability
45
bmiMD: 98. Royal Medical Center: 45.
94
Both Molecules
62
bmiMD: 94. Royal Medical Center: 62.
82
Easy Cancellation
58
bmiMD: 82. Royal Medical Center: 58.
70
Reputation
47
bmiMD: 70. Royal Medical Center: 47.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

Royal Medical Center

Royal Medical Center is a physician-led nationwide telehealth practice centered on hormone therapy that also offers a compounded tirzepatide weight-loss program (no semaglutide).

Why it's a deal

  • Physician founder Dr. Dagoberto Rodriguez, MD — Emory residency, former Coral Springs Medical Center chairman, U Miami faculty
  • Tirzepatide pricing fully itemized by dose tier ($450 / $650 / $800 / $1,100) — more transparent than 'starting at' floors
  • All-inclusive pricing bundles medication, supplies, injections, lab monitoring, and physician follow-ups
  • Broad catalog (HRT, TRT, peptides, ED, hair, vitamins) reflects an established multi-program clinic
  • Florida physician with 30+ years of practice — a strong physician-led care signal

The fine print

  • Operating legal entity not disclosed — only the 'Royal Medical Center' brand surfaced
  • Pharmacy partner not named — buyers can't verify licensure or 503A/503B status
  • No LegitScript badge displayed
  • States served not enumerated — site says 'nationwide' with no state list
  • Headline 'starting at $116/mo' conflicts with the actual $450/mo tirzepatide floor
Get the bmiMD deal Get the Royal Medical Center deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Royal Medical Center.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.